
|Articles|June 1, 2001
The American Journal of Managed Care
- June 2001
- Volume 7
- Issue 6
Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis
Advertisement
Articles in this issue
over 24 years ago
Does the HEDIS Asthma Measure Go Far Enough?over 24 years ago
Rheumatoid Arthritis: Guidelines for Emerging TherapiesNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Real-World Data Highlight Favorable Responses to Liso-Cel for R/R CLL
3
Top 5 Most-Read Mental Health Content of 2025
4
Baricitinib Shows Real-World Effectiveness in Severe Alopecia Areata Hair Loss
5







































